Outputs
TransPot Publications
Mantsiou, A., Vlahou, A. and Zoidakis, J. (2018): Tissue proteomics studies in the investigation of Prostate cancer, Expert Review of Proteomics, DOI: 10.1080/14789450.2018.1491796
Singh, P., Robson, C.N., Heer, R. (2018): In vitro prostate differentiation of induced pluripotent stem cells and organoid generation using seminal vesicle mesenchyme, Science Direct, DOI: 10.1016/S1569-9056(18)33034-3
Umbreen, S., Steele, R.E., Poulose, N., Mcdade, S., Mccabe, N., Mills, I.G. (2018): Approaches to enrich for androgen receptor binding sites in low-cell number samples, DOI: 10.1016/S1569-9056(18)32982-8
Kdadra, M., Höckner, S., Leung, H., Kremer, W., Schiffer, E., (2019): Metabolomics Biomarkers of Prostate Cancer: A Systematic Review, DOI: https://dx.doi.org/10.3390/diagnostics9010021
Abstracts
Abstracts from ESUR 2019 conference, Porto, Portugal, 10th – 12th October 2019 https://esur.uroweb.org/
ESR 1 Rafael Sanchez Martinez - SLFN5 regulates amino acid metabolism by altering LAT1 expression in CRPC
ESR 2 Parmveer Singh - In vitro prostate tissue generation using induced pluripotent stem cells and rodent seminal vesicle mesenchyme
ESR 3 Syed Umbreen - Evaluating multicellular contributions to the maintenance of AR activity under conditions of androgen deprivation
ESR 4 Syeda Afshan - Regulation of tumor-stroma interactions by FGF/FGFR signaling in prostate cancer progression: Study on in vitro and in vivo models
ESR 5 Annelies Van-Hemelryk - Pdx And Patient-Derived Prostate Cancer Organoids As A Cornerstone For High Throughput Drug Screens And Personalised Medicine
ESR 6 Kdadra Marouane - Assessment of Prostate Cancer Aggressiveness using metabolomics evaluation of urine by NMR Spectroscopy
ESR 7 Anna Mantsiou - Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer
ESR 8 Mina Sattari - Identification of novel long non-coding RNA based biomarkers in prostate cancer
ESR 9 Mario Cangiano - A transcription factor activity profile as a prognostic signature for recurrence predisposition in prostate cancer patients.
ESR 10 Cathal McKinney - Validation of a MEKK and DDRD gene expression signature in preclinical models
